Enveda is a clinical stage company that focuses on the discovery of new drugs from nature. The company leverages a platform that combines machine learning, metabolomics and robotics to explore nature's chemical diversity and accelerate the drug discovery and development process. Within 5 years, it has developed a robust pipeline composed of 10 drug candidates and 1 clinical programme at a speed four-times faster than the industry average. Enveda serves the healthcare sector.